Terminated OBSERVATIONAL NCT00808652

Prevalence and Outcome of Brachial Artery Endothelial Function in Morbidly Obese Patients Undergoing Bariatric Surgery

Sponsor: Sheba Medical Center

Conditions Ischemic Heart Disease Obesity, Morbid

Interventions Measurement of flow mediated dilation of brachial artery.

Updated 7 times since 2017 Last updated: May 5, 2016 Started: Mar 31, 2009 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

not enough recruits

Other terminated trials from Sheba Medical Center

See all terminations from Sheba Medical Center

Other Ischemic Heart Disease trials with similar outcome

Browse all Ischemic Heart Disease trials

Listed as NCT00808652, this observational or N/A phase trial focuses on Ischemic Heart Disease and Obesity, Morbid and remains terminated or withdrawn. Sponsored by Sheba Medical Center, it has been updated 7 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated
Sep 2024 — Sep 2025 [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Terminated NA

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sheba Medical Center

Data source: Sheba Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tel Litwinsky, Israel